content
List of IARC Group 1 carcinogens
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "List_of_IARC_Group_1_carcinogens" .
Substances, mixtures and exposure circumstances in this list have been classified by the IARC as Group 1 : The agent (mixture) is carcinogenic to humans. The exposure circumstance entails exposures that are carcinogenic to humans. This category is used when there is sufficient evidence of carcinogenicity in humans. Exceptionally, an agent (mixture) may be placed in this category when evidence of carcinogenicity in humans is less than sufficient but there is sufficient evidence of carcinogenicity in experimental animals and strong evidence in exposed humans that the agent (mixture) acts through a relevant mechanism of carcinogenicity.
Agents and groups of agents
Aflatoxins (naturally occurring mixtures of)
4-Aminobiphenyl
Arsenic and arsenic compounds 1
Asbestos
Azathioprine
Benzene
Benzidine
Beryllium and beryllium compounds 2
Chlornapazine (N,N-Bis(2-chloroethyl)-2-naphthylamine)
Bis(chloromethyl)ether
Chloromethyl methyl ether
1,4-Butanediol dimethanesulfonate (Busulphan; Myleran)
Cadmium and cadmium compounds 2
Chlorambucil
Methyl-CCNU (1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea; Semustine)
Chromium (VI) compounds2
Ciclosporin
Cyclophosphamide
Diethylstilboestrol
Dioxin
Epstein-Barr virus
Erionite
Ethylene oxide
Etoposide in combination with cisplatin and bleomycin
Formaldehyde
Gamma radiation
Gallium arsenide
Helicobacter pylori (infection with)
Hepatitis B virus (chronic infection with)
Hepatitis C virus (chronic infection with)
Herbal remedies containing plant species of the genus Aristolochia
Human immunodeficiency virus type 1 (infection with)
Human papillomavirus type 16
Human papillomavirus type 18
Human T-cell lymphotropic virus type I
Melphalan
Methoxsalen (8-Methoxypsoralen) plus ultraviolet A radiation
MOPP and other combined chemotherapy including alkylating agents
Mustard gas (Sulfur mustard)
2-Naphthylamine
Neutron radiation
Nickel compounds 2
Oestrogen therapy , postmenopausal
Oestrogens, nonsteroidal1
Oestrogens, steroidal1
Opisthorchis viverrini (infection with)
Combined forms of hormonal contraception (those containing both estrogen and a progestogen)3
Sequential forms of hormonal contraception (a period of estrogen-only followed by a period of both estrogen and a progestogen)
Phosphorus-32, as phosphate
Plutonium-239 and its decay products (may contain plutonium-240 and other isotopes), as aerosols
Radioiodines, short-lived isotopes, including iodine-131, from atomic reactor accidents and nuclear weapons detonation (exposure during childhood)
Radionuclides, α-particle-emitting, internally deposited4
Radionuclides, β-particle-emitting, internally deposited4
Radium-224 and its decay products
Radium-226 and its decay products
Radium-228 and its decay products
Radon-222 and its decay products
Schistosoma haematobium (infection with)
Silica , crystalline (inhaled in the form of quartz or cristobalite from occupational sources)
Solar radiation
Talc containing asbestiform fibres
Tamoxifen 5
2,3,7,8-Tetrachlorodibenzo-para-dioxin
Thiotepa (1,1',1"-Phosphinothioylidynetrisaziridine)
Thorium-232 and its decay products, administered intravenously as a colloidal dispersion of thorium-232 dioxide
Treosulfan
Vinyl chloride
X-Radiation
Mixtures
Exposure circumstances
Notes
This evaluation applies to the group of compounds as a whole and not necessarily to all individual compounds within the group.
Evaluated as a group.
There is also conclusive evidence that these agents have a protective effect against cancers of the ovary and endometrium.
Specific radionuclides for which there is sufficient evidence for carcinogenicity to humans are also listed individually as Group 1 agents.
There is also conclusive evidence that this agent (tamoxifen ) reduces the risk of contralateral breast cancer.
© jGames.co.uk 2007 (some content from Wikipedia under GDL )
!-- ValueClick Media 468x60 and 728x90 Banner CODE for jgames.co.uk -->